DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
代谢综合征血脂异常的饮食
基本信息
- 批准号:7144959
- 负责人:
- 金额:$ 76.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-15 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The metabolic syndrome (MetS) is comprised of a constellation of cardiovascular risk factors rooted in the current epidemic of obesity. Two of the defining features of MetS are high triglycerides and low HDL, i.e. the dyslipidemia of MetS. Standard hygienic recommendations for this dyslipidemia are weight loss and exercise, but at weight stability, there is no consensus on the dietary fat and carbohydrate proportions best suited for the dyslipidemia or the associated impaired vascular reactivity of MetS. Diets higher in fat, lower in carbohydrate may be more beneficial in MetS. Weight-loss studies show that higher fat, lower carbohydrate intakes are associated with lower triglyceride levels in obese persons, but lipoprotein, inflammatory and vascular responses to dietary perturbation in weight stability (the usual physiological state) have not been studied prospectively. Standard low fat, high carbohydrate diets in dyslipidemic persons yield 1/3rd of the LDL lowering of persons with simple hypercholesterolemia. Such persons are also less sensitive to higher saturated fat feeding. Consistent with these findings are lower rates of coronary disease in persons ingesting higher fat diets in observational studies. These observations plus physiological reasoning suggest the following hypothesis: Higher fat intake is more beneficial than conventional fat restricted diet in MetS for; 1) managing dyslipidemia, 2) reducing inflammatory stress and 3) correcting endothelium-mediated vascular reactivity, an immediate index of atherosclerotic stress. The study will compare the lipoprotein and vascular effects of two diets distinct in fat and carbohydrate content in a randomized, 4-week, crossover, feeding study design, using food prepared in the metabolic kitchen of the University of Washington GCRC. Diets will contain 40en% fat. 45en% carbohydrate or 20en% fat. 65en% carbohydrate with equivalent protein (15en%) and saturated fat (8en%). Weight will remain stable. Eligibility criteria are triglyceride >150mg/dl and any two other criteria of MetS. Seventy-two men and women will be randomized to yield 60 finished subjects at a 20% drop out rate. Weight and other vital signs will be measured twice weekly when food is picked-up from the GCRC. Lipoprotein lipids will be measured at 0, 3 and 4 weeks. Apoproteins B and A-l, LDL buoyancy, glucose, insulin, adiponectin, inflammatory cytokines and flow-mediated brachial artery reactivity will be measured at 0 and 4 weeks. A 4-month extension will continue the second diet assignment under dietician counseling with repeat testing. Expected results: 40en% fat diet in MetS subjects will yield improvements in non-HDL-C, other lipoprotein and glycemic variables, inflammation and brachial reactivity compared to 20en% fat. This study will be the first to demonstrate dietary benefit for dyslipidemia, inflammation and vascular stress in MetS at stable weight.
描述(申请人提供):代谢综合征(METS)是由一系列源于当前肥胖流行的心血管危险因素组成的。蛋氨酸的两个特征是高甘油三酯和低高密度脂蛋白,即蛋氨酸的血脂异常。治疗这种血脂异常的标准卫生建议是减肥和锻炼,但在体重稳定方面,对于最适合蛋氨酸代谢紊乱或相关血管反应性受损的饮食脂肪和碳水化合物比例,还没有达成共识。高脂肪、低碳水化合物的饮食可能对蛋氨酸更有益。减肥研究表明,肥胖者高脂肪、低碳水化合物摄入量与低甘油三酯水平相关,但在体重稳定(通常的生理状态)中,脂蛋白、炎症和血管对饮食扰动的反应还没有前瞻性的研究。标准低脂、高碳水化合物饮食对血脂异常人群的低密度脂蛋白降低率是单纯性高胆固醇血症患者的1/3。这类人对高饱和脂肪摄入也不太敏感。与这些发现一致的是,在观察性研究中,摄入高脂肪饮食的人患冠状动脉疾病的比率较低。这些观察和生理推理提出了以下假设:在蛋氨酸中,较高的脂肪摄入量比传统的脂肪限制饮食更有利于:1)控制血脂异常,2)减少炎症应激,3)纠正内皮介导的血管反应性,这是动脉粥样硬化应激的直接指标。这项研究将通过随机、为期4周的交叉喂养研究设计,使用在华盛顿大学GCRC代谢厨房准备的食物,比较两种脂肪和碳水化合物含量不同的饮食对脂蛋白和血管的影响。饮食中将含有40en%的脂肪。45EN%的碳水化合物或20EN%的脂肪。65en%的碳水化合物和等量的蛋白质(15en%)和饱和脂肪(8en%)。体重将保持稳定。资格标准是甘油三酯150 mg/dl和甲硫氨酸的任何两个其他标准。72名男性和女性将随机产生60名完成测试的受试者,辍学率为20%。从GCRC取食物时,体重和其他生命体征将每周测量两次。分别于0周、3周、4周测定血脂。分别于0周和4周检测载脂蛋白B和A-L、低密度脂蛋白浮力、血糖、胰岛素、脂联素、炎性细胞因子和血流介导的肱动脉反应性。延长4个月将继续在营养师咨询下进行第二次饮食分配,并进行重复测试。预期结果:与20en%的脂肪饮食相比,METS受试者40en%的脂肪饮食将在非高密度脂蛋白胆固醇、其他脂蛋白和血糖变量、炎症和臂部反应性方面产生改善。这项研究将首次证明饮食有益于稳定体重的蛋氨酸患者的血脂紊乱、炎症和血管应激。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT Henry KNOPP其他文献
ROBERT Henry KNOPP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT Henry KNOPP', 18)}}的其他基金
DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
代谢综合征血脂异常的饮食
- 批准号:
7440122 - 财政年份:2006
- 资助金额:
$ 76.97万 - 项目类别:
DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME
代谢综合征血脂异常的饮食
- 批准号:
7257033 - 财政年份:2006
- 资助金额:
$ 76.97万 - 项目类别:
EFFECT OF INSULIN RESISTANCE ON THE LIPOPROTEIN RESPONSE TO EGG FEEDING
胰岛素抵抗对脂蛋白对鸡蛋喂养反应的影响
- 批准号:
6113111 - 财政年份:1998
- 资助金额:
$ 76.97万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 76.97万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 76.97万 - 项目类别:














{{item.name}}会员




